Polycystic ovary syndrome (PCOS) is now estimated to affect roughly 20% of Indian women of reproductive age— among the highest national prevalence figures in the world. Weight is one of the very few levers that consistently improves PCOS symptoms across the board: irregular periods, acne, hair growth, fertility, insulin resistance.
Even modest weight loss — 5–10% of body weight — often restores ovulation and lowers androgen levels. GLP-1 therapy regularly delivers more than that.
Why insulin resistance drives PCOS
Most women with PCOS have some degree of insulin resistance — the cells don't respond to insulin normally, so the pancreas produces more, and chronically high insulin tells the ovaries to make extra testosterone. That's the chain that produces irregular periods, acne, and excess facial / body hair.
Anything that fixes the insulin resistance fixes the downstream hormones. Weight loss does it. Metformin does it partially. GLP-1 does it more powerfully than either.
What the evidence actually shows in PCOS
These outcomes don't happen because GLP-1 acts directly on the ovary — it doesn't. They happen because GLP-1 reduces weight and insulin resistance, and PCOS resolves downstreamof those.
Fertility: the most-asked question
Many women with PCOS struggle to conceive because they aren't ovulating regularly. Losing weight on GLP-1 frequently restores ovulation — including in women who've been told for years that they need IVF. That's a real outcome.
The catch: GLP-1 medications must be stopped before you actively try to conceive, and they're not safe in pregnancy.Most clinicians recommend a 2-month washout period after the last dose before trying.
The typical PCOS-fertility protocol we use:
- 6–9 months of GLP-1 to lose weight, restore cycles, lower androgens.
- Stop the medication, switch to dietary continuity + metformin if needed.
- Plan conception after 2 menstrual cycles off the medication.
Which medication, for PCOS specifically?
All GLP-1 medications work; the difference is in degree. For PCOS we tend to prefer:
- Semaglutide (Ozempic / Wegovy)— longest track record in PCOS studies. Good first-line choice.
- Tirzepatide (Mounjaro)— stronger insulin- sensitising effect (because of the GIP component). Worth considering when insulin resistance is severe (HbA1c > 6.0).
Either way, the dose is the same as for general weight management, titrated up over 12–16 weeks.
What to watch for as a woman on GLP-1
- Hormonal contraception: oral contraceptives are notknown to lose effectiveness on GLP-1. But if you've been told you can't get pregnant because of PCOS, the medication can change that — so contraception matters during treatment if you're sexually active and not actively trying to conceive.
- Iron + B12 levels: we check at baseline and at 6 months. Common deficiencies in vegetarian Indian women, sometimes amplified by reduced food intake.
- Bone density: rapid weight loss can affect bone health in younger women. Resistance training + adequate calcium is the standard guard.
When PCOS + GLP-1 isn't the right call
PCOS by itself, without overweight or metabolic risk, doesn't automatically qualify someone for GLP-1. If your BMI is in the normal range and your only PCOS symptom is irregular periods, first-line treatment is still lifestyle, metformin (if indicated), and oral contraceptives for cycle regulation.
GLP-1 enters the picture when there's weight + PCOS, or PCOS + metabolic comorbidity (insulin resistance, fatty liver, pre-diabetes).
- Jensterle M et al. Glucagon-like peptide-1 receptor agonists in polycystic ovary syndrome: a systematic review. Front Endocrinol 2022.
- ICMR Task Force on PCOS, India consensus statement 2022.
